Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1Classical hematology 1CNS 1

Conditions

Brain Neoplasms 264Glioblastoma 245Glioma 187Neuroblastoma 83Neoplasms 58Central Nervous System Neoplasms 53Astrocytoma 53Medulloblastoma 45Breast Neoplasms 42Sarcoma 38Melanoma 38Carcinoma, Non-Small-Cell Lung 37Neurofibromatosis 1 36Meningioma 35Ependymoma 35Lung Neoplasms 34Osteosarcoma 29Rhabdomyosarcoma 28Diffuse Intrinsic Pontine Glioma 27Sarcoma, Ewing 26Recurrence 26Rhabdoid Tumor 25Neoplasm Metastasis 25Oligodendroglioma 22Wilms Tumor 21Gliosarcoma 21Pancreatic Neoplasms 20Pheochromocytoma 19Hepatoblastoma 19Thyroid Neoplasms 18

Interventions

thymoglobulin 1fludarabine 1Rituximab 1Melphalan 1Levetiracetam 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Influenza, Human × CNS × 90 days × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡